HemaSphere (Jun 2022)

P543: TARGETING SAMHD1 WITH HYDROXYUREA IN FIRST-LINE CYTARABINE-BASED THERAPY OF NEWLY DIAGNOSED ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE HEAT-AML TRIAL

  • M. Jädersten,
  • I. Lilienthal,
  • N. Tsesmetzis,
  • M. Lourda,
  • S. Bengtzén,
  • A. Bohlin,
  • C. Arnroth,
  • T. Erkers,
  • B. Seashore-Ludlow,
  • G. Giraud,
  • G. S. Barkhordar,
  • S. Tao,
  • L. Fogelstrand,
  • L. Saft,
  • P. Östling,
  • R. Schinazi,
  • B. Kim,
  • T. Schaller,
  • G. Juliusson,
  • S. Deneberg,
  • S. Lehmann,
  • G. Rassidakis,
  • M. Höglund,
  • J.-I. Henter,
  • N. Herold

DOI
https://doi.org/10.1097/01.HS9.0000845060.66757.5c
Journal volume & issue
Vol. 6
pp. 442 – 443

Abstract

Read online

No abstracts available.